Stuart L. Graham

8 Macquarie St
Sydney, NSW 2000, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 201 publications

Impact of Continuous Positive Airway Pressure Treatment on Retinal Vasculature in Obstructive Sleep Apnea: A 7-Year Follow-Up.

Impact of Continuous Positive Airway Pressure Treatment on Retinal Vasculature in Obstructive Sleep Apnea: A 7-Year Follow-Up.

Journal: Investigative ophthalmology & visual science
Published: August 04, 2026

Invisible threats of microplastics induced toxicity: Oxidative and inflammatory pathways in the CNS and retina.

Invisible threats of microplastics induced toxicity: Oxidative and inflammatory pathways in the CNS and retina.

Journal: International review of neurobiology
Published: June 11, 2026

Synergistic retinal UCHL1 dysregulation and synaptic vulnerability reflect Alzheimer's disease severity.

Synergistic retinal UCHL1 dysregulation and synaptic vulnerability reflect Alzheimer's disease severity.

Journal: bioRxiv : the preprint server for biology
Published: February 12, 2026

Early Retinal UCHL1 Dysregulation Coupled With Synaptic Loss Reflects Alzheimer's Disease Severity.

Early Retinal UCHL1 Dysregulation Coupled With Synaptic Loss Reflects Alzheimer's Disease Severity.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 09, 2026

Retinal glial cells in glaucoma and age-related retinal diseases: Inflammatory responses, disease transitions, and translational perspectives.

Retinal glial cells in glaucoma and age-related retinal diseases: Inflammatory responses, disease transitions, and translational perspectives.

Journal: Neural regeneration research
Published: December 14, 2025

Selective Receptor Modulation by Truncated Neuropeptide Y (3-36) Dissociates Vasoconstriction from Neuroprotection in Experimental Glaucoma.

Selective Receptor Modulation by Truncated Neuropeptide Y (3-36) Dissociates Vasoconstriction from Neuroprotection in Experimental Glaucoma.

Journal: Molecular neurobiology
Published: October 09, 2025

A Multitrait Polygenic Risk Score for Open-Angle Glaucoma Stratifies Risk of Pigmentary Glaucoma in Pigment Dispersion Syndrome.

A Multitrait Polygenic Risk Score for Open-Angle Glaucoma Stratifies Risk of Pigmentary Glaucoma in Pigment Dispersion Syndrome.

Journal: Ophthalmology. Glaucoma
Published: September 04, 2025

Neuropeptide Y at the crossroads of neurodegeneration: Mechanistic insights and emerging therapeutic strategies.

Neuropeptide Y at the crossroads of neurodegeneration: Mechanistic insights and emerging therapeutic strategies.

Journal: Neuropeptides
Published: July 28, 2025

Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer's disease retina.

Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer's disease retina.

Journal: Research square
Published: July 18, 2025

Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer's disease retina.

Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer's disease retina.

Journal: bioRxiv : the preprint server for biology
Published: July 16, 2025

The Dynamic Roles of Repressor Element 1-Silencing Transcription Factor (REST): A Double-Edged Sword in Neural Health and Disease.

The Dynamic Roles of Repressor Element 1-Silencing Transcription Factor (REST): A Double-Edged Sword in Neural Health and Disease.

Journal: Molecular neurobiology
Published: July 02, 2025

Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer's disease retina.

Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer's disease retina.

Journal: Nature communications
Published: June 16, 2025
Showing 1-12 of 201

Last Updated: 09/26/2026